Purpose: The frequency of and factors associated with the use of resorptive medications among community-dwelling women age 45 years or older in Minnesota were studied. Methods: The study was a ...

The authors found that in all three models the indirect pro-osteoclastogenic and bone-resorptive effects of IFN-γ prevail over the direct anti-osteoclastogenic activity. The authors suggest that ...

Discover the latest advancements in osteoporosis treatment for postmenopausal women. New medications, including Romosozumab and Denosumab, offer hope and convenience, promising better bone health and ...

"Following an approach similar to that advocated for women with osteoporosis, we recommend the use of oral anti-resorptive agents as first-line agents in men at a high risk of fracture and the use of ...

So, the overall result of taking a medication for osteoporosis should be to increase your bone density. You may hear these types of medications called "anti-resorptive medications". It is important to ...

Risedronate is the latest of the bisphosphonates to be used for the management of resorptive bone disease. Clinical improvements, assessed by the incidence of fracture and changes in bone mineral ...

These substances appear to exert a synergistic effect, controlling activated monocytes and suppressing the secretion of bone resorptive inflammatory cytokines.” The study was conducted on a large ...